DiscoverOptimum PerspectivesLytix Biopharma – Innovations in Killing Cancer
Lytix Biopharma – Innovations in Killing Cancer

Lytix Biopharma – Innovations in Killing Cancer

Update: 2024-03-07
Share

Description

Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer.

Hosted on Acast. See acast.com/privacy for more information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Lytix Biopharma – Innovations in Killing Cancer

Lytix Biopharma – Innovations in Killing Cancer